Iptacopan

CHEMBL4594448 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

422.5 g/mol

LogP

1.8

Phase

4

An oral complement factor B inhibitor for paroxysmal nocturnal hemoglobinuria.

Molekularmasse

422,5000 g/mol

LogP

1,80

TPSA

74,80 Å²

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Age-Related Macular Degeneration Systemic Lupus Erythematosus

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

CCO[C@H]1CCN(Cc2c(OC)cc(C)c3[nH]ccc23)[C@H](c2ccc(C(=O)O)cc2)C1

InChI

InChI=1S/C25H30N2O4/c1-4-31-19-10-12-27(22(14-19)17-5-7-18(8-6-17)25(28)29)15-21-20-9-11-26-24(20)16(2)13-23(21)30-3/h5-9,11,13,19,22,26H,4,10,12,14-15H2,1-3H3,(H,28,29)/t19-,22-/m0/s1

Molecular Formula

C25H30N2O4

HBD / HBA

2 / 5

Rotierbare Bindungen

7

Schwere Atome

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

An oral complement factor B inhibitor for paroxysmal nocturnal hemoglobinuria.

Yes, Iptacopan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4594448. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 90467622. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Iptacopan auf PillFYI

Struktur

Schnelldaten

Formel: C25H30N2O4
Synonyme: 1

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.